SG Americas Securities LLC raised its stake in Koninklijke Philips (NYSE:PHG – Get Rating) by 10.1% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 35,001 shares of the technology company’s stock after buying an additional 3,198 shares during the period. SG Americas Securities LLC’s holdings in Koninklijke Philips were worth $539,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in PHG. Price T Rowe Associates Inc. MD lifted its stake in Koninklijke Philips by 15.5% in the second quarter. Price T Rowe Associates Inc. MD now owns 39,303,903 shares of the technology company’s stock valued at $844,622,000 after buying an additional 5,280,066 shares during the period. BlackRock Inc. raised its position in shares of Koninklijke Philips by 59.6% during the first quarter. BlackRock Inc. now owns 4,430,980 shares of the technology company’s stock worth $135,277,000 after purchasing an additional 1,655,150 shares during the period. Wellington Management Group LLP raised its position in shares of Koninklijke Philips by 16.7% during the first quarter. Wellington Management Group LLP now owns 8,245,236 shares of the technology company’s stock worth $251,727,000 after purchasing an additional 1,178,744 shares during the period. Renaissance Technologies LLC raised its position in shares of Koninklijke Philips by 476.3% during the first quarter. Renaissance Technologies LLC now owns 1,283,821 shares of the technology company’s stock worth $39,289,000 after purchasing an additional 1,061,054 shares during the period. Finally, FMR LLC raised its position in shares of Koninklijke Philips by 20.6% during the second quarter. FMR LLC now owns 6,030,927 shares of the technology company’s stock worth $129,846,000 after purchasing an additional 1,030,242 shares during the period. Institutional investors and hedge funds own 10.17% of the company’s stock.
Wall Street Analyst Weigh In
PHG has been the topic of a number of research analyst reports. Jefferies Financial Group lowered Koninklijke Philips from a “buy” rating to a “hold” rating in a research report on Tuesday, October 18th. JPMorgan Chase & Co. dropped their price target on Koninklijke Philips from €18.80 ($20.43) to €10.90 ($11.85) in a research report on Tuesday, November 1st. Deutsche Bank Aktiengesellschaft downgraded Koninklijke Philips from a “hold” rating to a “sell” rating in a report on Friday, October 14th. UBS Group downgraded Koninklijke Philips from a “neutral” rating to a “sell” rating in a report on Tuesday, January 17th. Finally, Morgan Stanley decreased their price objective on Koninklijke Philips from €17.00 ($18.48) to €16.00 ($17.39) and set an “equal weight” rating for the company in a report on Tuesday, January 17th. Four analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $18.56.
Koninklijke Philips Stock Performance
Koninklijke Philips (NYSE:PHG – Get Rating) last released its quarterly earnings data on Monday, October 24th. The technology company reported $0.25 earnings per share (EPS) for the quarter. The company had revenue of $4.31 billion during the quarter, compared to analysts’ expectations of $4.36 billion. Koninklijke Philips had a positive return on equity of 7.50% and a negative net margin of 6.09%. The business’s revenue was up 3.7% on a year-over-year basis. During the same period last year, the firm posted $0.47 earnings per share. On average, equities research analysts expect that Koninklijke Philips will post 0.62 earnings per share for the current year.
Koninklijke Philips Profile
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
- Get a free copy of the StockNews.com research report on Koninklijke Philips (PHG)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- Analysts Like The Fit Of Skechers USA
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.